GGrantIndex
Sort

326,823 grants matching clinical trial

Regulatory Support for Cancer Prevention Agent Development

$2,823,722
Caroline Sigman · Ccs Associates, Inc. · N02 · FY2021 · CA

An Open Source Research Permissions Framework for South Carolina

$2,823,426
Jay Moskowitz · University Of South Carolina At Columbia · RC2 · FY2009 · LM

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,823,331
Robert A. Rizza · Mayo Clinic Rochester · UL1 · FY2006 · RR

LC - IMPAACT Leadership Group

$2,823,246
Grace M. Aldrovandi · Children'S Hospital Of Los Angeles · UM1 · FY2015 · AI

Neurobiology of Addiction

$2,823,151
George Koob · National Institute On Drug Abuse · ZIA · FY2024 · DA

Support of NCI CCR Clinical Research and Bioinformatics

$2,823,146
Jeffrey Shilling · Division Of Basic Sciences - Nci · ZIH · FY2011 · CA

CTSA INFRASTRUCTURE FOR AIDS RESEARCH

$2,823,010
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR

CTSA INFRASTRUCTURE FOR AIDS RESEARCH

$2,823,009
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR

Collective Intelligence, Knowledge Infrastructure, & High Performance Computing

$2,823,000
Calvin A Johnson · Center For Information Technology · ZIH · FY2010 · CT

Hepatitis B Research Network - Data Coordination Center

$2,822,874
Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · DK

An Adaptation of Project Northland for Urban Youth

$2,822,546
University Of Minnesota Twin Cities · R01 · FY2004 · AA

The University of Kansas Cancer Center

$2,822,506
Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2022 · CA

Colorectal Chemoprevention with Calcium and Vitamin D

$2,822,236
Dartmouth College · R01 · FY2003 · CA

Institute for Clinical and Translational Science

$2,822,221
Dan M Cooper · University Of California-Irvine · UL1 · FY2017 · TR

Shared Resource Management

$2,821,399
Erwin G Van Meir · University Of Alabama At Birmingham · P30 · FY2022 · CA

Shared Resource Management

$2,821,399
Erwin G Van Meir · University Of Alabama At Birmingham · P30 · FY2023 · CA

Shared Resource Management

$2,821,396
Erwin G Van Meir · University Of Alabama At Birmingham · P30 · FY2024 · CA

A RADOMIZED, DOUBLE-BLIND, PLACEBO-CONROLLED TRIAL OF DOXAZOSIN FOR NIGHTMARES, SLEEP DISTURBANCE, AND NON-NIGHTMARE CLINICAL SYMPTOMS IN POST-TRAUMA

$2,821,185
Northern California Institute For Research And Education, Inc. · · FY2017 · Defense Health Agency

Bone Marrow Transplantation in Human Disease

$2,820,874
Richard J Jones · Johns Hopkins University · P01 · FY2011 · CA

Targeted Bone Regeneration via Activation of Resident Stem Cells

$2,820,500
Tracey Rogers · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR

Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention

$2,820,494
Robert Rodick · Vxbiosciences, Inc. · R01 · FY2021 · AI

Investigation On The Behavioral Effects And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.

$2,820,374
Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2024 · DA

New methods to measure and interrupt metabolic fluxes in brain cancer

$2,820,337
Daniel R Wahl · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Targeting Cellular Senescence to Extend Healthspan

$2,819,749
Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2023 · AG

Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART

$2,819,529
Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2017 · AI